DIXARIT

This brand name is authorized in Estonia, United Kingdom, South Africa

Active ingredients

The drug DIXARIT contains one active pharmaceutical ingredient (API):

1 Clonidine UNII W76I6XXF06 - CLONIDINE HYDROCHLORIDE

Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone. Read about Clonidine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIXARIT Coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CX02	Clonidine	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CX Other antimigraine preparations
Discover more medicines within N02CX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1725498
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161596, 199609
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/7.3/139